These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3488728)

  • 1. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.
    Haxby JV; Grady CL; Duara R; Schlageter N; Berg G; Rapoport SI
    Arch Neurol; 1986 Sep; 43(9):882-5. PubMed ID: 3488728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.
    Haxby JV; Grady CL; Koss E; Horwitz B; Heston L; Schapiro M; Friedland RP; Rapoport SI
    Arch Neurol; 1990 Jul; 47(7):753-60. PubMed ID: 2357155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: metabolic uncoupling of associative brain regions.
    Rapoport SI; Horwitz B; Haxby JV; Grady CL
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):540-5. PubMed ID: 3491664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: longitudinal confirmation.
    Haxby JV; Grady CL; Friedland RP; Rapoport SI
    J Neural Transm Suppl; 1987; 24():49-53. PubMed ID: 3479529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.
    Pietrini P; Alexander GE; Furey ML; Hampel H; Guazzelli M
    Int J Psychophysiol; 2000 Jul; 37(1):87-98. PubMed ID: 10828377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.
    Grady CL; Haxby JV; Horwitz B; Sundaram M; Berg G; Schapiro M; Friedland RP; Rapoport SI
    J Clin Exp Neuropsychol; 1988 Oct; 10(5):576-96. PubMed ID: 3265710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment.
    Haxby JV; Rapoport SI
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):427-38. PubMed ID: 3541045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
    Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.
    Rapoport SI; Horwitz B; Grady CL; Haxby JV; DeCarli C; Schapiro MB
    Adv Exp Med Biol; 1991; 291():231-48. PubMed ID: 1927686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease].
    Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.
    Haxby JV; Duara R; Grady CL; Cutler NR; Rapoport SI
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):193-200. PubMed ID: 3988821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
    Herholz K
    Expert Rev Neurother; 2010 Nov; 10(11):1667-73. PubMed ID: 20977325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography in Alzheimer's disease.
    Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.